Search Results 1071-1080 of 19326 for Hemoglobin

  1. PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...

  2. Global Trial in APG2575 for Patients With CLL/​SLL - Mayo Clinic

    * Total hemoglobin ≥ 9 g/dL, 5. Adequate renal function * Creatinine clearance must be \> 50 ml/min directly measured with 24hr urine collection or ...

  3. A Study To Evaluate Tranexamic Acid (TXA) Versus Placebo To Reduce Perioperative Blood Transfusion In Patients Undergoing Liver Resection - Mayo Clinic

    Severe anemia (hemoglobin (Hgb) levels <90 g/l). Documented arterial or venous thrombosis at screening or in past three months (not including therapeutic ...

  4. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Hemoglobin < 10 g/dL; or; WBC < 3.0 x 103/mm^3; or; Platelet count < 100,000 ... Hemoglobin A1C > 7.5%, confirmed by repeat. Urine drug screen positive ...

  5. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    Hemoglobin >= 8 g/dL (may be supported). Patients with a known seizure disorder should be stable and should not have experienced a significant increase in ...

  6. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL. Creatinine ≤ 1.5 x upper limit of normal (ULN). In patients with creatinine > 1.5 x ULN, if measured or calculated creatinine ...

  7. Publications - Adam R. Miller, M.D. - Mayo Clinic

    The Utility of Hemoglobin A1c at Diagnosis for Prediction of Future Glycemic Control in Children with Type 1 Diabetes. Diabetes Research and Clinical ...

  8. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

    Hemoglobin < 100 g/L;; NT-proBNP ≥ 500 pg/mL. If one of these criteria is not met based on central laboratory report, a re-test must be performed before ...

  9. A Study to Evaluate Infigratinib to Treat Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302) - Mayo Clinic

    Hemoglobin 1 week before randomization and hemoglobin remains stable. Have insufficient hepatic and renal function: Total bilirubin > 1.5 × upper limit of ...

  10. A Study to Evaluate AntiThrombotic Therapy to Lessen Complications of COVID-19 (Enrolling by Invitation Only) - Mayo Clinic

    Hemoglobin < 80 g/L (to minimize the likelihood of requiring red blood cell transfusion if potential bleeding were to occur). Acute or subacute bacterial ...